Paul Neff
Director/Board Member at ACRES COMMERCIAL REALTY CORP.
Net worth: 347 661 $ as of 2024-04-29
Profile
Paul Sherrill Neff founded Quaker Partners Management LP in 2002, where he is working as Founding Partner from 2003.
Mr. Neff also currently works at ACRES Commercial Realty Corp., as Independent Director from 2005, RainDance Technologies, Inc., as Director from 2011, Intact Vascular, Inc., as Director from 2013, and Greater Philadelphia Venture Group, as Director.
Mr. Neff also formerly worked at Resource America, Inc., as Director from 1998 to 2005, Neose Technologies, Inc., as Director from 2002 to 2003, Biolex Therapeutics, Inc., as Director, Amicus Therapeutics, Inc., as Director from 2005 to 2011, Regado Biosciences, Inc., as Director from 2005 to 2014, Neuronetics, Inc., as Director from 2006 to 2015, Cempra Pharmaceuticals, Inc., as Independent Director from 2011 to 2017, Rapid Micro Biosystems, Inc., as Director, Optherion, Inc., as Director, Cempra, Inc., as Director in 2011, Alex.
Brown & Sons, Inc., as Managing Director from 1984 to 1993, Cellgate, Inc., as Director, The Bancorp, Inc. (Delaware), as Director from 1999 to 2002, Medmark, Inc., as Director, BioRexis Pharmaceutical Corp., as Director, University City Science Center, as Director, National Venture Capital Association, as Director from 2009 to 2013, The Biotechnology Institute, as Director, Durata Therapeutics, Inc., as Director, Jefferson Bank (Dallas, Texas), as Director, Vesper Medical, Inc., as Director, KBL Merger Corp.
IV, as Independent Director from 2017 to 2020, US Healthcare, Inc., as Senior Vice President-Corporate Development, Quaker Partners LLC, as Partner, Morgan, Lewis & Bockius LLP, as Attorney from 1980 to 1984, and Life Sciences Pennsylvania, as President.
Mr. Neff received his undergraduate degree from Wesleyan University and graduate degree from The University of Michigan Law School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-05-06 | 25,451 ( 0.33% ) | 347 661 $ | 2024-04-29 |
Paul Neff active positions
Companies | Position | Start |
---|---|---|
ACRES COMMERCIAL REALTY CORP. | Director/Board Member | 2005-02-28 |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | Founder | 2002-12-31 |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | Director/Board Member | 2012-12-31 |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | Director/Board Member | 2011-01-31 |
Greater Philadelphia Venture Group | Director/Board Member | - |
Former positions of Paul Neff
Companies | Position | End |
---|---|---|
180 LIFE SCIENCES CORP. | Director/Board Member | 2020-11-08 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Director/Board Member | 2016-12-31 |
NEURONETICS, INC. | Director/Board Member | 2014-12-31 |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Director/Board Member | 2012-12-31 |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Paul Neff
Wesleyan University | Undergraduate Degree |
The University of Michigan Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
ACRES COMMERCIAL REALTY CORP. | Finance |
AMICUS THERAPEUTICS, INC. | Health Technology |
THE BANCORP, INC. | Finance |
NEURONETICS, INC. | Health Technology |
RAPID MICRO BIOSYSTEMS, INC. | Producer Manufacturing |
Private companies | 26 |
---|---|
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Resource America, Inc.
Resource America, Inc. Investment ManagersFinance Resource America, Inc. is an asset management company, which engages in real estate and credit investments. Its objective is to be best in class among asset managers in the real estate and credit sectors as measured by returns to investors and the funds and businesses it manages. The company was founded in 1966 and is headquartered in Philadelphia, PA. | Finance |
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Health Technology |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
Medmark, Inc.
Medmark, Inc. Pharmaceuticals: MajorHealth Technology Medmark, Inc. manufactures and distributes pharmaceutical products. The company was founded in 2003 and is headquartered in Carnegie, PA. | Health Technology |
US Healthcare, Inc.
US Healthcare, Inc. Medical/Nursing ServicesHealth Services Part of CVS Health Corp., US Healthcare, Inc. is a company that provides healthcare services for individuals, families, and businesses. US Healthcare, Inc. is based in Blue Bell, PA. US Healthcare was acquired by Aetna, Inc., part of CVS Health Corp. from November 29, 2018 on July 19, 1996 for $8,114.05 million. The company was founded by Benad Goldwasser, Angelo Masciantonio. | Health Services |
Alex. Brown & Sons, Inc. | Finance |
Morgan, Lewis & Bockius LLP
Morgan, Lewis & Bockius LLP Miscellaneous Commercial ServicesCommercial Services Morgan, Lewis & Bockius LLP provides legal consulting services. It specializes in transactional, litigation, labor and employment, regulatory, and intellectual property legal services to various industries. The company was founded in 1873 and is headquartered in Philadelphia, PA. | Commercial Services |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a "per patient, per setting" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ. | Health Technology |
Optherion, Inc.
Optherion, Inc. Medical SpecialtiesHealth Technology Optherion, Inc. develops therapeutic products. It develops products to diagnose and treat dry and wet Age-related Macular Degeneration and other chronic diseases involving the alternative complement system. The company was founded by Gregory S. Hageman, David I. Scheer and Sandy Gordon in 2005 and is headquartered in New Haven, CT. | Health Technology |
Greater Philadelphia Venture Group | |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Commercial Services |
The Biotechnology Institute
The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Commercial Services |
Cellgate, Inc.
Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Progen Pharmaceuticals, Inc. develops biopharmaceuticals products. It is engaged in developing improved drug delivery based on their transporter molecules. The company is headquartered in Redwood City, CA. | Health Technology |
University City Science Center
University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Miscellaneous |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | Health Technology |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Health Technology |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Commercial Services |
Biolex Therapeutics, Inc.
Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Biolex Therapeutics, Inc. developed and produced drugs. The company was founded in 1997 and was headquartered in Pittsboro, NC. | Distribution Services |
Jefferson Bank (Dallas, Texas) | Finance |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | Health Technology |
Durata Therapeutics, Inc.
Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
Vesper Medical, Inc.
Vesper Medical, Inc. Medical SpecialtiesHealth Technology Vesper Medical, Inc. develops minimally-invasive peripheral vascular products. It creates a venous stent portfolio that addresses the multiple anatomical challenges presented by the iliac and femoral veins. The company was founded in 2016 and is headquartered in Wayne, PA. | Health Technology |
KBL Merger Corp. IV
KBL Merger Corp. IV Financial ConglomeratesFinance KBL Merger Corp. IV is a blank check company, which focuses on acquiring an operating company in the healthcare and related wellness industry. The company was founded on September 7, 2016 and is headquartered in New York, NY. | Finance |
Quaker Partners LLC
Quaker Partners LLC Investment ManagersFinance Part of GWA LLC, Quaker Partners LLC is a venture capital fund. The company is based in Hartford, CT. | Finance |
- Stock Market
- Insiders
- Paul Neff